Latest news
September 15, 2005
Debiovision Inc., a speciality pharmaceutical developer joins the Debio companies
June 27, 2005
Debiopharm and Neovacs sign License and Equity Agreement for the development fo Neovacs´ anti-TNF-Alpha product
April 21, 2005
Debiopharm and NanoCarrier form Research Collaboration on a new platinum compound using the Medicelle TM technology
March 1, 2005
Debiopharm S.A. announces the purchase of all outstanding shares of H3 Pharma
February 7, 2005
Debiopharm S.A. announces marketing approval for a new formulation of Eloxatin® (Oxaliplatin for injection)
Stay informed
Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.